Latest news
BlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:09:00 GMTCancer to Superbugs: What AI-Designed Viruses Could Be Used For - NewsweekNewsweek · Fri, 07 Aug 2026 12:45:00 GMTAI-designed first-in-class small-molecule inhibitor shows preclinical promise against pancreatic cancer - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 22:18:47 GMTFirst-in-class small molecule inhibitor designed with AI support shows promise against pancreatic cancer in preclinical studies - Mayo Clinic News NetworkMayo Clinic News Network · Wed, 05 Aug 2026 13:41:08 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity NewsMedCity News · Tue, 04 Aug 2026 20:22:15 GMTPathos AI Closes $2.3B Cancer Drug Deals to Prove AI Can Design Smarter Trials - Tech TimesTech Times · Tue, 04 Aug 2026 19:03:51 GMTInsilico Medicine's AI-Designed Cancer Drug Secures FDA Fast Track Status - BioPharma APACBioPharma APAC · Fri, 31 Jul 2026 07:00:00 GMTIncyte cuts early-stage cancer drug to focus on next-gen programs - BioSpaceBioSpace · Wed, 29 Jul 2026 07:00:00 GMT